Author

Jeffrey N. Joyce

Observed names: J JOYCE, J Joyce, J N Joyce, J. Joyce, J. N. JOYCE, J. N. Joyce, J.N Joyce, J.N. Joyce, JEFFREY N. JOYCE, JN Joyce, Jeffery N. Joyce, Jeffrey Joyce, Jeffrey N Joyce, JeffreyN. Joyce

Institutions: Marshfield Clinic, Marshfield Clinic

Observed institutions: Marshfield Clinic, Children's Hospital of Philadelphia, Royal College of Surgeons in Ireland, Emory University, University of Illinois Urbana-Champaign, University of California, Irvine, University of Illinois System, University Hospital of Basel, University of Florida, Marshfield Clinic, Banner Sun Health Research Institute, Valleywise Health, University of Pennsylvania, University of Edinburgh

ORCID: 0000-0002-0131-0946

Observed ORCID: 0000-0002-0131-0946

OpenAlex ID: A5014426745

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

2010 · Stephen M. Massa, Tao Yang, et al. · Journal of Clinical Investigation · 403

Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics

1993 · Jeffrey N. Joyce, Audi Shane, et al. · Neuropsychopharmacology · 340

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.

1994 · A M Murray, H L Ryoo, et al. · Proceedings of the National Academy of Sciences · 327

PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis

2007 · A. Lockhart, J.R. Lamb, et al. · Brain · 311

PDF

Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

2003 · Steven P. Presgraves, Tariq Ahmed, et al. · Neurotoxicity Research · 302

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

2009 · Tetyana Duka, Valeriy Duka, et al. · The FASEB Journal · 279

Neuroinflammation in Alzheimer's Disease and Parkinson's Disease: Are Microglia Pathogenic in Either Disorder?

2007 · Joseph Rogers, Diego Mastroeni, et al. · International review of neurobiology · 264

Effects of estrogen on the basal ganglia

1986 · Carol Van Hartesveldt, Jeffrey N. Joyce · Neuroscience & Biobehavioral Reviews · 240

Dopamine D3 receptor antagonists as therapeutic agents

2005 · Jeffrey N. Joyce, Mark J. Millan · Drug Discovery Today · 239

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

2001 · Jeffrey N. Joyce · Pharmacology & Therapeutics · 219

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

2010 · Jonathan Wills, Jessica Jones, et al. · Experimental Neurology · 218

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

1997 · Eugenia V. Gurevich, Jeffrey N. Joyce · Biological Psychiatry · 181

Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia

1988 · Jeffrey N. Joyce, Nedra Lexow, et al. · Synapse · 168

Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents

1987 · J.N. Joyce, J.F. Marshall · Neuroscience · 168

Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study

1991 · Peter A. Rao, Perry B. Molinoff, et al. · Developmental Brain Research · 166

Serotonergic involvement in haloperidol-induced catalepsy.

1993 · B S Neal-Beliveau, J N Joyce, et al. · Journal of Pharmacology and Experimental Therapeutics · 150

Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation

1985 · Jeffrey N. Joyce, Steve K. Loeschen, et al. · Brain Research · 147

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra

1999 · S.Y. Ma, B.J. Ciliax, et al. · The Journal of Comparative Neurology · 146

Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

1995 · Angela M. Murray, Fredric B. Weihmueller, et al. · Annals of Neurology · 138

Microglial responses to dopamine in a cell culture model of Parkinson's disease

2008 · Diego Mastroeni, Andrew Grover, et al. · Neurobiology of Aging · 133

Postmortem analysis of adrenal–medulla–to–caudate autograft in a patient with parkinson's disease

1989 · Howard Hurtig, Jeffrey Joyce, et al. · Annals of Neurology · 133

Environmental complexity modulates growth of granule cell dendrites in developing but not adult hippocampus of rats

1978 · Beverly A. Fiala, Jeffrey N. Joyce, et al. · Experimental Neurology · 129

Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia

1997 · J Joyce · Neuropsychopharmacology · 124

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

1989 · John F. Marshall, Rommel Navarrete, et al. · Brain Research · 123

Increases in Dopamine D3 Receptor Binding in Rats Receiving a Cocaine Challenge at Various Time Points after Cocaine Self-Administration: Implications for Cocaine-Seeking Behavior

2004 · Janet L Neisewander, Rita A Fuchs, et al. · Neuropsychopharmacology · 121

Works count: 132

Citation count: 8,882

H-index: 52

I10-index: 97